179 related articles for article (PubMed ID: 21990014)
1. Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495).
Woo LW; Ganeshapillai D; Thomas MP; Sutcliffe OB; Malini B; Mahon MF; Purohit A; Potter BV
ChemMedChem; 2011 Nov; 6(11):2019-34. PubMed ID: 21990014
[TBL] [Abstract][Full Text] [Related]
2. Development of steroid sulfatase inhibitors.
Woo LW; Purohit A; Potter BV
Mol Cell Endocrinol; 2011 Jul; 340(2):175-85. PubMed ID: 21238537
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors.
El-Gamal MI; Semreen MH; Foster PA; Potter BV
Bioorg Med Chem; 2016 Jun; 24(12):2762-7. PubMed ID: 27143133
[TBL] [Abstract][Full Text] [Related]
4. New potent steroid sulphatase inhibitors based on 6-(1-phenyl-1
Ciupak O; Daśko M; Biernacki K; Rachon J; Masłyk M; Kubiński K; Martyna A; Demkowicz S
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):238-247. PubMed ID: 33322953
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors.
Moi D; Foster PA; Rimmer LG; Jaffri A; Deplano A; Balboni G; Onnis V; Potter BVL
Eur J Med Chem; 2019 Nov; 182():111614. PubMed ID: 31422224
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors.
Hng Y; Lin MH; Lin TS; Liu IC; Lin IC; Lu YL; Chang CN; Chiu PF; Tsai KC; Chen MJ; Liang PH
Bioorg Chem; 2020 Mar; 96():103618. PubMed ID: 32059152
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism of irosustat, a novel steroid sulfatase inhibitor: interspecies comparison, metabolite identification, and metabolic enzyme identification.
Ventura V; Solà J; Celma C; Peraire C; Obach R
Drug Metab Dispos; 2011 Jul; 39(7):1235-46. PubMed ID: 21464173
[TBL] [Abstract][Full Text] [Related]
8. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
[TBL] [Abstract][Full Text] [Related]
9. The Design, Structure-Activity, and kinetic studies of 3-Benzyl-5-oxa-1,2,3,4-Tetrahydro-2H-chromeno-(3,4-c)pyridin-8-yl sulfamates as Steroid sulfatase inhibitors.
Chang CN; Lin IC; Lin TS; Chiu PF; Lu YL; Narwane M; Liu IC; Hng Y; Tsai KC; Lin MH; S Y Hsieh Y; Chen MJ; Liang PH
Bioorg Chem; 2022 Dec; 129():106148. PubMed ID: 36244324
[TBL] [Abstract][Full Text] [Related]
10. A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation.
El-Gamal MI; Zaraei SO; Foster PA; Anbar HS; El-Gamal R; El-Awady R; Potter BVL
Bioorg Med Chem; 2020 Apr; 28(8):115406. PubMed ID: 32173116
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of analogues of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors.
Lawrence Woo LW; Leblond B; Purohit A; Potter BV
Bioorg Med Chem; 2012 Apr; 20(8):2506-19. PubMed ID: 22455789
[TBL] [Abstract][Full Text] [Related]
12. 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Lehr P; Billich A
J Med Chem; 2002 Sep; 45(19):4310-20. PubMed ID: 12213072
[TBL] [Abstract][Full Text] [Related]
13. Steroid sulfatase inhibitors: the current landscape.
Anbar HS; Isa Z; Elounais JJ; Jameel MA; Zib JH; Samer AM; Jawad AF; El-Gamal MI
Expert Opin Ther Pat; 2021 Jun; 31(6):453-472. PubMed ID: 33783295
[No Abstract] [Full Text] [Related]
14. IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer.
Palmieri C; Szydlo R; Miller M; Barker L; Patel NH; Sasano H; Barwick T; Tam H; Hadjiminas D; Lee J; Shaaban A; Nicholas H; Coombes RC; Kenny LM
Breast Cancer Res Treat; 2017 Nov; 166(2):527-539. PubMed ID: 28795252
[TBL] [Abstract][Full Text] [Related]
15. Design, structure-activity relationships, and enzyme kinetic studies of tricyclic and tetracyclic coumarin-based sulfamates as steroid sulfatase inhibitors.
Chiu PF; Lin IC; Lu YL; Chang CN; Chan HY; Lin TS; Tsai KC; Hsieh YSY; Chen MJ; Lin MH; Liang PH
Bioorg Chem; 2023 Sep; 138():106581. PubMed ID: 37172437
[TBL] [Abstract][Full Text] [Related]
16. Steroid Sulphatase and Its Inhibitors: Past, Present, and Future.
Foster PA
Molecules; 2021 May; 26(10):. PubMed ID: 34064842
[TBL] [Abstract][Full Text] [Related]
17. Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.
Okada M; Nakagawa T; Iwashita S; Takegawa S; Fujii T; Koizumi N
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):141-8. PubMed ID: 14672734
[TBL] [Abstract][Full Text] [Related]
18. D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase.
Fischer DS; Woo LW; Mahon MF; Purohit A; Reed MJ; Potter BV
Bioorg Med Chem; 2003 Apr; 11(8):1685-700. PubMed ID: 12659755
[TBL] [Abstract][Full Text] [Related]
19. Aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templates.
Wood PM; Woo LW; Thomas MP; Mahon MF; Purohit A; Potter BV
ChemMedChem; 2011 Aug; 6(8):1423-38. PubMed ID: 21608133
[TBL] [Abstract][Full Text] [Related]
20. Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer.
Palmieri C; Januszewski A; Stanway S; Coombes RC
Expert Rev Anticancer Ther; 2011 Feb; 11(2):179-83. PubMed ID: 21342037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
